Effect of SGLT2 Inhibitors on Type 2 Diabetes Mellitus With Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials

OBJECTIVE: Clinical trials showed that sodium-glucose cotransporter 2 (SGLT2) inhibitors can improve non-alcoholic fatty liver disease (NAFLD). In this work, a meta-analysis of randomized controlled trials was conducted to evaluate the effect of SGLT2 inhibitors on type 2 diabetes mellitus (T2DM) wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Qiong, Xu, Xinyue, Guo, Li, Li, Jia, Li, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247927/
https://www.ncbi.nlm.nih.gov/pubmed/34220701
http://dx.doi.org/10.3389/fendo.2021.635556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247927/
https://www.ncbi.nlm.nih.gov/pubmed/34220701
http://dx.doi.org/10.3389/fendo.2021.635556

Ejemplares similares